Copyright Reports & Markets. All rights reserved.

Global Lipid Nanoparticle (LNP) Formulation Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Lipid Nanoparticle (LNP) Formulation Service by Type
    • 1.3.1 Overview: Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Lipid Nanoparticle (LNP) Formulation Service Consumption Value Market Share by Type in 2025
    • 1.3.3 mRNA-lipid Nanoparticle
    • 1.3.4 siRNA-lipid Nanoparticle
    • 1.3.5 Other
  • 1.4 Global Lipid Nanoparticle (LNP) Formulation Service Market by Application
    • 1.4.1 Overview: Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Gene Therapy
    • 1.4.3 Vaccine
    • 1.4.4 Cancer Treatment
  • 1.5 Global Lipid Nanoparticle (LNP) Formulation Service Market Size & Forecast
  • 1.6 Global Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast by Region
    • 1.6.1 Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Lipid Nanoparticle (LNP) Formulation Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Lipid Nanoparticle (LNP) Formulation Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Lipid Nanoparticle (LNP) Formulation Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Cytiva
    • 2.1.1 Cytiva Details
    • 2.1.2 Cytiva Major Business
    • 2.1.3 Cytiva Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.1.4 Cytiva Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Cytiva Recent Developments and Future Plans
  • 2.2 Croda International
    • 2.2.1 Croda International Details
    • 2.2.2 Croda International Major Business
    • 2.2.3 Croda International Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.2.4 Croda International Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Croda International Recent Developments and Future Plans
  • 2.3 Evonik
    • 2.3.1 Evonik Details
    • 2.3.2 Evonik Major Business
    • 2.3.3 Evonik Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.3.4 Evonik Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Evonik Recent Developments and Future Plans
  • 2.4 Merck KGaA
    • 2.4.1 Merck KGaA Details
    • 2.4.2 Merck KGaA Major Business
    • 2.4.3 Merck KGaA Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.4.4 Merck KGaA Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Merck KGaA Recent Developments and Future Plans
  • 2.5 Genevant Sciences
    • 2.5.1 Genevant Sciences Details
    • 2.5.2 Genevant Sciences Major Business
    • 2.5.3 Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.5.4 Genevant Sciences Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Genevant Sciences Recent Developments and Future Plans
  • 2.6 Nippon Fine Chemical
    • 2.6.1 Nippon Fine Chemical Details
    • 2.6.2 Nippon Fine Chemical Major Business
    • 2.6.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.6.4 Nippon Fine Chemical Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Nippon Fine Chemical Recent Developments and Future Plans
  • 2.7 Polymun Scientific
    • 2.7.1 Polymun Scientific Details
    • 2.7.2 Polymun Scientific Major Business
    • 2.7.3 Polymun Scientific Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.7.4 Polymun Scientific Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Polymun Scientific Recent Developments and Future Plans
  • 2.8 Corden Pharma
    • 2.8.1 Corden Pharma Details
    • 2.8.2 Corden Pharma Major Business
    • 2.8.3 Corden Pharma Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.8.4 Corden Pharma Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Corden Pharma Recent Developments and Future Plans
  • 2.9 Acuitas Therapeutics
    • 2.9.1 Acuitas Therapeutics Details
    • 2.9.2 Acuitas Therapeutics Major Business
    • 2.9.3 Acuitas Therapeutics Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.9.4 Acuitas Therapeutics Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Acuitas Therapeutics Recent Developments and Future Plans
  • 2.10 Creative Biolabs
    • 2.10.1 Creative Biolabs Details
    • 2.10.2 Creative Biolabs Major Business
    • 2.10.3 Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.10.4 Creative Biolabs Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Creative Biolabs Recent Developments and Future Plans
  • 2.11 GenScript
    • 2.11.1 GenScript Details
    • 2.11.2 GenScript Major Business
    • 2.11.3 GenScript Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.11.4 GenScript Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 GenScript Recent Developments and Future Plans
  • 2.12 WuXi STA
    • 2.12.1 WuXi STA Details
    • 2.12.2 WuXi STA Major Business
    • 2.12.3 WuXi STA Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.12.4 WuXi STA Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 WuXi STA Recent Developments and Future Plans
  • 2.13 MicroNano Biologics
    • 2.13.1 MicroNano Biologics Details
    • 2.13.2 MicroNano Biologics Major Business
    • 2.13.3 MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.13.4 MicroNano Biologics Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 MicroNano Biologics Recent Developments and Future Plans
  • 2.14 Precigenome
    • 2.14.1 Precigenome Details
    • 2.14.2 Precigenome Major Business
    • 2.14.3 Precigenome Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.14.4 Precigenome Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Precigenome Recent Developments and Future Plans
  • 2.15 Catalent
    • 2.15.1 Catalent Details
    • 2.15.2 Catalent Major Business
    • 2.15.3 Catalent Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.15.4 Catalent Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Catalent Recent Developments and Future Plans
  • 2.16 Wacker
    • 2.16.1 Wacker Details
    • 2.16.2 Wacker Major Business
    • 2.16.3 Wacker Lipid Nanoparticle (LNP) Formulation Service Product and Solutions
    • 2.16.4 Wacker Lipid Nanoparticle (LNP) Formulation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Wacker Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Lipid Nanoparticle (LNP) Formulation Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Lipid Nanoparticle (LNP) Formulation Service by Company Revenue
    • 3.2.2 Top 3 Lipid Nanoparticle (LNP) Formulation Service Players Market Share in 2025
    • 3.2.3 Top 6 Lipid Nanoparticle (LNP) Formulation Service Players Market Share in 2025
  • 3.3 Lipid Nanoparticle (LNP) Formulation Service Market: Overall Company Footprint Analysis
    • 3.3.1 Lipid Nanoparticle (LNP) Formulation Service Market: Region Footprint
    • 3.3.2 Lipid Nanoparticle (LNP) Formulation Service Market: Company Product Type Footprint
    • 3.3.3 Lipid Nanoparticle (LNP) Formulation Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Lipid Nanoparticle (LNP) Formulation Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Lipid Nanoparticle (LNP) Formulation Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Lipid Nanoparticle (LNP) Formulation Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Lipid Nanoparticle (LNP) Formulation Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Type (2021-2032)
  • 6.2 North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Application (2021-2032)
  • 6.3 North America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country
    • 6.3.1 North America Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Lipid Nanoparticle (LNP) Formulation Service Market Size by Country
    • 7.3.1 Europe Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Market Size by Region
    • 8.3.1 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Type (2021-2032)
  • 9.2 South America Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Application (2021-2032)
  • 9.3 South America Lipid Nanoparticle (LNP) Formulation Service Market Size by Country
    • 9.3.1 South America Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Market Size by Country
    • 10.3.1 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Lipid Nanoparticle (LNP) Formulation Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Lipid Nanoparticle (LNP) Formulation Service Market Drivers
  • 11.2 Lipid Nanoparticle (LNP) Formulation Service Market Restraints
  • 11.3 Lipid Nanoparticle (LNP) Formulation Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Lipid Nanoparticle (LNP) Formulation Service Industry Chain
  • 12.2 Lipid Nanoparticle (LNP) Formulation Service Upstream Analysis
  • 12.3 Lipid Nanoparticle (LNP) Formulation Service Midstream Analysis
  • 12.4 Lipid Nanoparticle (LNP) Formulation Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Lipid Nanoparticle (LNP) Formulation Service market size was valued at US$ 569 million in 2025 and is forecast to a readjusted size of US$ 1251 million by 2032 with a CAGR of 12.0% during review period.
    LNPs (Lipid Nanoparticles) are a novel potential delivery tool in the 100-150 nanometer range, serving as an important alternative to polymer systems. LNPs are lipophilic substances that have been shown to effectively deliver nucleic acid-based therapeutic products. This delivery system utilizes biocompatible lipid materials as carriers, capable of dissolving, encapsulating, adsorbing, and attaching drugs or other bioactive substances. Compared to other delivery systems, LNPs offer numerous advantages, including enhanced drug absorption, modified drug toxicity, improved drug stability, and controlled drug release. As a result, LNPs play an increasingly important role in the delivery of gene therapies, anticancer drugs, proteins, and peptides.
    Driven by the expanding pipeline of RNA therapeutics—including mRNA vaccines, siRNA drugs, and gene editing modalities—demand for LNP formulation services has surged across both early discovery and late-stage clinical development. The market is increasingly dominated by integrated CDMO providers with end-to-end capabilities in lipid synthesis, formulation optimization, scale-up, and GMP manufacturing. Leading players such as WuXi STA, Merck, and Evonik are capturing global demand through platform-based offerings and commercial-scale capacity. The sector is witnessing dual consolidation: top-tier CDMOs are gaining share via one-stop service models, while proprietary LNP delivery platforms remain concentrated among a few with ionizable lipid expertise and high encapsulation efficiency. Despite rapid growth, high raw material costs and complex process validation remain key bottlenecks. Future cost compression is expected through modular manufacturing, in-house lipid production, and standardized LNP platforms. Chinese firms are rapidly scaling up their capabilities to serve both domestic nucleic acid innovators and global mRNA vaccine export projects, with select players poised to become competitive globally.
    This report is a detailed and comprehensive analysis for global Lipid Nanoparticle (LNP) Formulation Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Lipid Nanoparticle (LNP) Formulation Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Lipid Nanoparticle (LNP) Formulation Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Lipid Nanoparticle (LNP) Formulation Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Lipid Nanoparticle (LNP) Formulation Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Lipid Nanoparticle (LNP) Formulation Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Lipid Nanoparticle (LNP) Formulation Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, Croda International, Evonik, Merck KGaA, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Lipid Nanoparticle (LNP) Formulation Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    mRNA-lipid Nanoparticle
    siRNA-lipid Nanoparticle
    Other
    Market segment by Application
    Gene Therapy
    Vaccine
    Cancer Treatment
    Market segment by players, this report covers
    Cytiva
    Croda International
    Evonik
    Merck KGaA
    Genevant Sciences
    Nippon Fine Chemical
    Polymun Scientific
    Corden Pharma
    Acuitas Therapeutics
    Creative Biolabs
    GenScript
    WuXi STA
    MicroNano Biologics
    Precigenome
    Catalent
    Wacker
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Lipid Nanoparticle (LNP) Formulation Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Lipid Nanoparticle (LNP) Formulation Service, with revenue, gross margin, and global market share of Lipid Nanoparticle (LNP) Formulation Service from 2021 to 2026.
    Chapter 3, the Lipid Nanoparticle (LNP) Formulation Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Lipid Nanoparticle (LNP) Formulation Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Lipid Nanoparticle (LNP) Formulation Service.
    Chapter 13, to describe Lipid Nanoparticle (LNP) Formulation Service research findings and conclusion.

    Buy now